Subjects
- Drug Resistance1
- Economics, Pharmaceutical1
- Enzyme Inhibitors -- therapeutic use1
- Financing, Personal1
- Formularies1
- Health Services Accessibility1
- Heart Failure -- diagnosis1
- Heart Failure -- drug therapy1
- Hypercholesterolemia -- therapy1
- Hyperlipoproteinemia Type II -- prevention & control1
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy1
- Medicare -- economics1
- Medicare Part D -- economics1
- Neprilysin -- administration & dosage1
- Neprilysin -- antagonists & inhibitors1
- Neprilysin -- economics1
- New England1
- Off-Label Use -- economics1
- Outcome and Process Assessment (Health Care)1
- Pilot Projects1